Sign in
Back
Multiple Myeloma, Version 1.2020 Featured Updates to the NCCN Guidelines
Journal article   Open access

Multiple Myeloma, Version 1.2020 Featured Updates to the NCCN Guidelines

Shaji K. Kumar, Natalie S. Callender, Jens Hillengass, Michaels Liedtke, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, Jason C. Chandler, Robert F. Cornell, Caitlin Costello, …
Journal of the National Comprehensive Cancer Network, Vol.17(10), pp.1155-1165
2019-10-01
DOI: https://doi.org/10.6004/jnccn.2019.0049
PMID: 31590151

Abstract

Life Sciences & Biomedicine Oncology Science & Technology
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.
url
https://doi.org/10.6004/jnccn.2019.0049View
Published (Version of record) Open

Metrics

5 Record Views
98 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.130 Lymphomas
1.130.617 Multiple Myeloma
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details